Clinical Trial
. 1992 Jan 30;326(5):347; author reply 348.
Vaccination with gp160 in HIV
- PMID: 1728747
Item in Clipboard
Clinical Trial
Vaccination with gp160 in HIV
N Engl J Med.
.
No abstract available
Comment on
-
A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research.N Engl J Med. 1991 Jun 13;324(24):1677-84. doi: 10.1056/NEJM199106133242401. N Engl J Med. 1991. PMID: 1674589 Clinical Trial.
Similar articles
-
Vaccination with gp160 in HIV.N Engl J Med. 1992 Jan 30;326(5):347-8. N Engl J Med. 1992. PMID: 1728748 No abstract available.
-
Vaccination with gp160 in HIV.N Engl J Med. 1992 Jan 30;326(5):347; author reply 348. doi: 10.1056/NEJM199201303260514. N Engl J Med. 1992. PMID: 1558566 No abstract available.
-
Current progress in HIV vaccines.Mo Med. 1991 Nov;88(11):762-5. Mo Med. 1991. PMID: 1805131 Review. No abstract available.
-
AIDS vaccine boosts immunity in HIV patients.RN. 1991 Oct;54(10):103. RN. 1991. PMID: 1925340 No abstract available.
-
Human trials of AIDS vaccines: current status and future directions.AIDS. 1989;3 Suppl 1:S125-9. AIDS. 1989. PMID: 2558684 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical